Search News

Corporate Industry Technology Medical Updates

extracorporeal ventricular assist device

Technology
magAssist's extracorporeal artificial heart product made the first public appearance at an international academic conference 2019-11-28
Corporate
magAssist Presents MoyoAssist® at ESAO 2024, Advancing Global Dialogue in Artificial Organ Technology 2024-09-26
Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth 2023-07-28
Corporate
The Chinese Start-Up Advancing Life Support Tech 2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14
Corporate
magAssist, Founding Member of “Suzhou-Soochow Overseas Chinese Entrepreneurship and Innovation Alliance”, Facilitates Innovation and Entrepreneurship of Returned Students 2023-01-16
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device” 2023-01-06
Corporate
magAssist Included in List of 2022 Potential Unicorn Companies in Jiangsu Province 2022-12-15
Corporate
Highlights｜magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application 2022-12-12

Tabs： artificial organs, interventional therapy, Percutaneous VAD, life support in case of multi-organ failure, a short-term full maglev ventricular assist device, critical care life support scenarios, minimally-invasive, How Artificial Heart Works, a leading company in treating heart failures, short-term bridging heart transplant patients, Conference,